Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy.
Dastoli S, Passante M, Loconsole F, Mortato E, Balato A, Piccolo V, Guarneri C, Macca L, Provenzano E, Valenti G, D'Amico D, Micali G, Musumeci ML, Palazzo G, Foti C, Romita P, Fabbrocini G, Megna M, Sammarra I, Bennardo L, Patruno C.
Dastoli S, et al. Among authors: sammarra i.
J Dermatolog Treat. 2023 Dec;34(1):2200868. doi: 10.1080/09546634.2023.2200868.
J Dermatolog Treat. 2023.
PMID: 37026590
Free article.